Program - Interventional Oncology Sans Frontieres(IOSF

Transcription

Program - Interventional Oncology Sans Frontieres(IOSF
www.iosfc2016.org
INTERVENTIONAL ONCOLOGY
SANS FRONTIERES (IOSF) CONGRESS 2016
and 1st World Congress on FUSION IMAGING and
AUGMENTED REALITY for Interventional Procedures
Milan, Italy - July 7- 9, 2016
ATA Hotel Expo Fiera - Via Giovanni Keplero,12 Pero - MI
ORGANIZING
and SCIENTIFIC COMMITTEE:
Luigi Solbiati
S. Nahum Goldberg
Franco Orsi
Fusion Imaging
and Augmented Reality
SCIENTIFIC COMMITTEE:
Giovanni Mauri
Anastasios Michos
Francesco DiMeco
Francesco Prada
Guido Torzilli
Index
Welcome Letter
3
Congress Map 4
Expo Area
5
Faculty
6
IOSF CME Credits
Endorsements
Organizing Secretariat
Official Travel Agency
8
General Information
9
Scientific Program
Thursday, July 7th
10
Scientific Program
Friday, July 8th
13
Scientific Program
Saturday, July 9th
15
Abstracts
17
Congress Venue
How to reach Atahotel Expo Fiera
22
Main Sponsors
23
2
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
Dear Friends and Colleagues,
Welcome to our Meeting
“Interventional Oncology Sans Frontières” (IOSF)
that follows the very successful previous Meeting in 2013
in Cernobbio (Como Lake).
Our Organizing Committee, comprising the key world opinion leaders
in this field, has particularly constructed the Meeting to be exciting
and informative on multiple levels with many innovations
and the participation of international colleagues.
Luigi Solbiati, S. Nahum Goldberg, Franco Orsi
for the IO Sans Frontières Organizing Committee
Luigi SOLBIATI, MD
S. Nahum GOLDBERG, MD, FSIR
Franco ORSI, MD
Professor of Radiology,
Humanitas University
and Research Hospital
Rozzano (Milano), ITALY
Vice-Chairman, Research,
Director Image-guided Therapies
and Tumor Ablation
Dept. of Radiology
Hadassah Hebrew University Med. Center
Jerusalem, ISRAEL
Chairman,
Dept. of Interventional Radiology
IEO European Institute of Oncology,
Milano ITALY
[email protected]
[email protected]
[email protected]
[email protected]
3
Congress Map
4
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
Expo Area
5
Faculty
Ahmed Muneeb (USA - Boston)
Beth Israel Deaconess Medical Center
de Baere Thierry (FRANCE - Paris)
Institut Gustav Roussy
Aliberti Camillo (ITALY - Padova)
IRCCS Istituto Oncologico Veneto
DiMeco Francesco (ITALY - Milano)
Istituto Neurologico Besta
Anselmetti Giovanni Carlo (ITALY - Milano)
IEO European Institute of Oncology
Donadon Matteo (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Arai Yasuaki (JAPAN - Tokyo)
National Cancer Center Hospital
Fischer Thomas (GERMANY - Berlin)
Ultrasound Research Laboratory
of the Charité Campus Mitte
Baek Jung Hwan (SOUTH KOREA - Seoul)
Asan Medical Center Ulsan University Hospital
Bale Reto (AUSTRIA - Innsbruck)
University Clinic of Radiology Innsbruck
Medical University
Gadaleta Cosmo (ITALY - Bari)
IRCCS Ospedale Oncologico Giovanni Paolo II
Geschwind Jeff (USA - New Haven)
Yale University School of Medicine
Balzarini Luca (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Gillams Alice (UK - London)
The London Clinic
Basso Curzio (ITALY - Genova)
Camelot Biomedical Systems
Giuliante Felice (ITALY - Roma)
Policlinico Gemelli
Bizzarri Giancarlo
(ITALY - Albano Laziale - Roma)
Ospedale Regina Apostolorum
Golby Alexandra (USA - Boston)
Brigham and Women’s Hospital
Breen David (UK - Southampton)
University Hospital of Southampton
Goldberg Nahum
(ISRAEL - Jerusalem)
Hadassah Hebrew University Medical Center
Brountzos Elias (GREECE - Athens)
University of Athens
Hasegawa Kiyoshi (JAPAN - Tokyo)
Graduate School of Medicine, University of Tokyo
Brown Karen T. (USA - New York)
Memorial Sloan Kettering Cancer Center
Helmberger Thomas (GERMANY - Munich)
Klinikum Bogenhausen
Burgmans Mark (NETHERLANDS - Leiden)
LUMC, Leiden University Hospital
Hinshaw Louis J. (USA - Madison )
Univ. of Wisconsin, School of Medicine
and Public Health
Cazzato Roberto Luigi (FRANCE - Strasbourg)
Nouvel Hôpital Civil,
Hôpitaux Universitaires de Strasbourg
Jereczek Barbara Alicia (ITALY - Milano)
IEO European Institute of Oncology
Cerri Giovanni (BRAZIL - Sao Paulo)
University of Sao Paulo
Jung Ernst-Michael (GERMANY - Regensburg)
University Hospital of Regensburg
Chiti Arturo (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Kelekis Alexis (GREECE - Athens)
Attikon University Hospital
Cianni Roberto (ITALY - Latina)
Ospedale Santa Maria Goretti
Lazzari Roberta (ITALY - Milano)
IEO European Institute of Oncology
Cillo Umberto (ITALY - Padova)
Policlinico Universitario di Padova
Lee Min Woo (SOUTH KOREA - Seoul)
Samsung Medical Center
Crocetti Laura (ITALY - Pisa)
Azienda Ospedaliera Universitaria Cisanello
Lever Alex (UK - London)
Selex ES
Curigliano Giuseppe (ITALY - Milano)
IEO European Institute of Oncology
Lewandowski Robert (USA - Chicago)
Northwestern Medical Group
6
Malagari Katarina (GREECE - Athens)
University of Athens
Sardanelli Francesco (ITALY - San Donato M. - Milano)
Policlinico San Donato
Matei Victor (ITALY - Milano)
IEO European Institute of Oncology
Scorsetti Marta (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Mauri Giovanni (ITALY - Milano)
IEO European Institute of Oncology
Selbekk Tormod (NORWAY - Trondheim)
SINTEF Medical Technology
Meloni Franca M. (ITALY - Milano)
Casa di Cura Igea
Shiina Shuichiro (JAPAN - Tokyo)
Juntendo University
Meng Zhiqiang (CHINA - Shanghai)
Fudan Cancer Center
Sofocleous Constantinos (USA - New York)
Memorial Sloan Kettering Cancer Center
Michos Anastasios (SWEDEN - Stockholm)
Karolinska Institute
Solbiati Luigi (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Montorsi Marco (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Solomon Steve (USA - New York)
Memorial Sloan Kettering Cancer Center
Narayanan Govindarajan (USA - Miami)
University of Miami
Steno Andrej (SLOVAKIA - Bratislava)
University Hospital Bratislava
Orecchia Roberto (ITALY - Milano)
IEO European Institute of Oncology
Strunk Holger (GERMANY - Bonn)
University of Bonn
Orsi Franco (ITALY - Milano)
IEO European Institute of Oncology
Torzilli Guido (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Pece Salvatore (ITALY - Milano)
IEO European Institute of Oncology
van Strijen Marco (NETHERLANDS - Nieuwegein)
St. Antonius Ziekenhuis
Pedicini Vittorio (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Viganò Luca (ITALY Rozzano - Milano)
Humanitas University and Research Hospital
Pereira Philippe (GERMANY - Heilbronn)
SLK-Kliniken
Wood Brad (USA - Bethesda)
National Institutes of Health
Perin Alessandro (ITALY - Milano)
Istituto Neurologico Besta
Zvi Ram (ISRAEL - Tel Aviv)
Sourasky Medical Center
Ping Liang (CHINA - Beijing)
PLA General Hospital
Corporate Speakers
Poretti Dario (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
Prada Francesco (ITALY - Milano)
Istituto Neurologico Besta
Rhim Hyunchul (SOUTH KOREA - Seoul)
Samsung Medical Center
Richter Goetz M. (GERMANY - Stuttgart)
Klinik für Diagnostische und
Interventio­nelle Radiologie
Tosoratti Nevio
(HS - Hospital Service)
Serra Piero
(River Global Group)
Solbiati Marco
(Raw s.r.l)
Gold Medal Awarded
Ricke Jens (GERMANY - Magdeburg)
DAfMT, Deutsche Akademie für Mikrotherapie
Tito Livraghi (Italy - Vimercate Milano)
Salem Riad (USA - Chicago)
Northwestern University
William Charboneau (USA Rochester - MN)
Min-Hua Chen (China - Beijing)
Santoro Armando (ITALY - Rozzano - Milano)
Humanitas University and Research Hospital
7
IOSFC CME Credits
The IOSFC 2016 will be accredited at the European Accreditation Council for medical Education
(EACCME) and at the Italian Continuing Medical Education (CME)
Disciplines accepted are: Physicians - Radiographers - Nurses
The attendance to the sessions is verified through a magnetic badge combined with the Congress Badge. Assistants placed at the entrance will pass a reader on badge bar codes in order
to scan entrance/exit to/from the Congress Simposia. Only participants who have attended the
Congress and completed the IOSFC CME TEST will obtain CME/EACCME credit certificate.
A system for Continuing Medical Education (CME) is aimed to assure a high level of theoretic
and clinical competence throughout the working life of medical specialists. Doctors are faced
with an exploding amount of literature and new technologies as well as a concern about escalating medical costs with a great emphasis on efficacy. CME provides educational activities, which
allow to maintain, develop and increase medical knowledge and skill and to improve professional
performances with the aim to ensure better and safer treatments for the patients. The UEMS European Union of Medical Specialists is representing 34 European Countries.
The IOSFC was granted:
18.0 European CME credits by the European Accreditation for Continuing Medical Education (EACCME)
11.0 Italian CME credits by the Agenzia Nazionale per i Servizi Regionali (Age.Na.S.)
Endorsements
Organizing Secretariat
ARSEDUCANDI Srl
Viale Gian Galeazzo, 3
20136 Milano, ITALY
Web: www.arseducandi.it
e-mail: [email protected]
Official Travel Agency
PV Agency S.P.A
Viale Gian Galeazzo, 3
20136 Milano, ITALY
Web: www.pvagency.it
8
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
General Information
Congress Registration
EARLY BIRD RATE
Until
April 6th, 2016
From April 7th
to June 7th, 2016
From June 8th
to June 20th, 2016
Physician
€ 550,00 VAT INCLUDED
€ 700,00 VAT INCLUDED
€ 850,00 VAT INCLUDED
Physician registered
€ 500,00 VAT INCLUDED
to a Scientific Society*
€ 650,00 VAT INCLUDED
€ 800,00 VAT INCLUDED
Radiographer / Nurse /
€175,00 VAT INCLUDED
Resident**
€ 225,00 VAT INCLUDED
€ 275,00 VAT INCLUDED
Medical Student ***
€ 50,00 VAT INCLUDED
€ 50,00 VAT INCLUDED
€ 50,00 VAT INCLUDED
Non-exhibiting
Industries
€ 550,00 VAT INCLUDED
€ 700,00 VAT INCLUDED
€ 850,00 VAT INCLUDED
Exhibiting Industries
€ 550,00 VAT INCLUDED
€ 700,00 VAT INCLUDED
€ 850,00 VAT INCLUDED
One Day registration
€ 300,00 VAT INCLUDED
€ 300,00 VAT INCLUDED
€ 300,00 VAT INCLUDED
Please note that an additional on-site fee of € 60,00 will be applied.
Credit card payment only with Visa and Mastercard
Cancellation will be accepted until June 19th, 2016 with refund of the amount paid - 50 euros (fee charge)
* To benefit from membership fees, physicians must indicate in the Registration Form their Scientific Society of affiliation and membership number.
** Radiographer/Nurses and Resident (under the age of 35) must submit by e-mail or by fax a certificate signed by the Head of the Department and a
copy of a valid ID together with their registration.
*** Medical students (under the age of 27) must submit by e-mail or by fax a certificate of study and a copy of a valid ID together with their registration.
Registration Fee Includes:
- Admission to all scientific sessions (only for Physician)
- Admission to scientific exhibition
- Admission to technical exhibition
- Congress materials
- Certificate of attendance
- Refreshment breaks and lunch daily
- Social dinner
9
Scientific Program
Thursday, July 7th
08:15 - 8:40
Registration
08:40 - 09:00
Welcome and Introduction
09:00 - 09:20
Keynote Lecture - Chairman: Nahum S. Goldberg
20 years of ablation: Past, present and future
Organizing Committee
Giovanni Cerri
Steve Solomon
State-Of-Art Of Technology
Imaging - Chairmen: Luca Balzarini - Philippe Pereira
09:25 - 09:40
Cone beam technology: How did we ever work
without it ?
Marco van Strijen
09:40 - 09:55
CEUS for the guidance of thermal ablation:
Current reliability and advancements
Ernst-Michael Jung
09:55 -10:10
CEUS and TAE/TACE: A new “marriage”
Dario Poretti
10:10 -10:20
Real-time ablation monitoring: Elastosonography
makes the dream come true
Laura Crocetti
10:20 - 10:35
MRI for guidance: How do I justify it ?
Philippe Pereira
10:35 - 10:50
Imaging and follow-up: When and how ?​​​​​
Thomas Helmberger
10:50 - 11:00
DISCUSSION
11:00 - 11:10
COFFEE BREAK
11:10 - 11:30
Keynote Lecture: Chairman: Roberto Orecchia
Cancer stem cells as a target for therapeutic
intervention in cancer
Salvatore Pece
ABLATION - Chairmen: S. Nahum Goldberg - Marco Montorsi
11:30 - 12:00
RF vs MW: How do I choose ?
* MW: In 2016 it’s the only way to go
Franca Meloni
* But I still love using Radiofrequency
Alice Gillams
12:00 - 12:15
Microwave ablation - Is it living up to the hype ?
J. Louis Hinshaw
12:15 - 12:30
Irreversible electroporation: State of the art
Govindarajan Narayanan
12:30 - 12:45
HIFU: State of the art
Franco Orsi
10
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
12:45 - 12:50
DISCUSSION
12:50 - 13:10
Keynote Lecture: Chairman: Marco Montorsi
Systemic effects of ablation
13:15 - 13:55
S. Nahum Goldberg
Lunch Symposium TECNOLOGIE AVANZATE
V-IORT: new strategy for vertebral mets. The EIO experience
Chairman: Franco Orsi
13:15 - 13:35
V-IORT: surgical approach
Giancarlo Anselmetti
13:35 - 13:55
V-IORT: clinical indications
Roberta Lazzari
1st WORLD MEETING on FUSION IMAGING and
AUGMENTED REALITY
for INTERVENTIONAL PROCEDURES
FUSION IMAGING and NAVIGATION in INTERVENTIONAL ONCOLOGY
Chairmen: Luigi Solbiati - Brad Wood
14:00 - 14:20
Navigation tools: An overview
14:20 - 15:10
Are they really useful for liver ablations ?
15:10 - 15:35
Brad Wood
* The Italian experience
Giovanni Mauri
*The European experience
Anastasios Michos
* The Chinese experience
Liang Ping
* The Korean experience (S-Fusion)
Min Woo Lee
Extrahepatic applications
* Virtual Navigation: Prostate, lung and neck
Giancarlo Bizzarri
* Prostate interventions with irreversible
electroporation
Thomas Fischer
15:35 - 15:45
Where will Fusion Imaging and Navigation
be in 3 years ?
15:45 - 15:55
DISCUSSION
15:55 - 16:15
COFFEE BREAK
11
​Luigi Solbiati
FUSION IMAGING and NAVIGATION in NEUROSURGERY
Chairmen: Francesco DiMeco - Zvi Ram
16:15 - 16:30
Multimodal visualization in interventional
procedures
Tormod Selbekk
16:30 - 16:45
Fusion imaging in neurosurgery
Francesco Prada
16:45 - 17:00
3D navigated ultrasound
Andrej Steno
FUSION IMAGING and NAVIGATION in ABDOMINAL SURGERY
Chairmen: Kiyoshi Hasegawa - Guido Torzilli
17:05 - 17:20
Fusion imaging and fluorescence for strategic
surgical planning
Kiyoshi Hasegawa
17:20 - 17:35
Fusion imaging for the surgical management
of colorectal liver metastases
Guido Torzilli
17:35 - 17:50
Fusion imaging as a tool for facilitating
surgeons’ training in intraoperative navigation​​​​​
Matteo Donadon
the FUTURE: INTEGRATED MULTIMODAL IMAGING, AUGMENTED REALITY and
NOVEL PARADIGMS for INTERVENTIONAL TRAINING
Chairmen: Francesco DiMeco - Francesco Prada
17:55 - 18:10
The AMIGO suite: A surgical innovation laboratory
Alexandra Golby
18:10 - 18:50
- Intra-operative US simulation for neurosurgical
training
Curzio Basso
- Simulation techniques: From high-tech aviation to Alex Lever
high-risk surgery
- New candidates’ selection and teaching
paradigms in neurosurgery: Preliminary
experience at the Besta NeuroSim Center
18:50 - 19:00
DISCUSSION and CONCLUSIONS
12
Alessandro Perin
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
Friday, July 8
th
CUTTING EDGE I O PRACTICE by ORGAN SYSTEM: Part 1
HCC: 20 years of thermal ablation - Chairmen: Constantinos Sofocleous - Guido Torzilli
08:30 - 08:45
RFA: Results and lessons learned
Shuichiro Shiina
08:45 - 09:00
RFA: Still relevant for HCC ?
​​Hyunchul Rhim
09:00 - 09:10
Can we raise the bar using Microwaves ?
Franca Meloni
Luigi Solbiati
09:10 - 09:25
Ablation for intermediate HCC: extending BCLC
guidelines
Reto Bale
09:25 - 09:40
Is BCLC therapeutic flow-chart still applicable ?
Philippe Pereira
09:40 - 09:55
I O treatments in a Transplant Center
​​​Umberto Cillo
09:55 - 10:10
Evolving role of combination therapies
S. Nahum Goldberg
10:10 - 10:20
DISCUSSION
HEPATIC COLORECTAL METASTASES - Chairmen: Felice Giuliante - Armando Santoro
10:20 - 10:35
Conservative ablation
Constantinos Sofocleous
10:35 - 10:50
Aggressive ablation
Alice Gillams
10:50 - 11:05
Stereotactic body radiation therapy vs ablation
Marta Scorsetti
11:05 - 11:15
DISCUSSION
11:15 - 11:35
COFFEE BREAK
LUNG - Chairmen: Thierry De Baere - Barbara Alicia Jereczek
11:35 - 11:50
We can do quite a bit with ablation
11:50 - 12:05
We can do even better adding chemoembolization Cosmo Gadaleta
12:05 - 12:20
Radiation therapy is just fine, thank you
12:20 - 12:30
DISCUSSION
12:50 - 13:40
Lunch Symposium HOSPITAL SERVICE
​​Steve Solomon
Marta Scorsetti
Next generation HS AMICA: the new ablation paradigm
Chairman: Luigi Solbiati
12:50 - 13:15
The HS AMICA revolution: higher power,
enhanced control, extended usability
Nevio Tosoratti
13:15 - 13:40
Ablavision: taking ablation to a higher standard
through pre-and post-treatment image processing
Marco Solbiati
13
13:40 - 14:00
Keynote Lecture - Chairman: Franco Orsi
TAE or TACE ? The ultimate answer !
Karen Brown
THE ARTERIAL ROUTE TO THE TUMOR
HCC - Chairmen: Elias Brountzos - Vittorio Pedicini
14:00 - 14:15
Conventional TACE: Why Asia does it better ?
Yasuaki Arai​
14:15 - 14:30
TACE 2.0: Eluting beads: The first generation
Katerina Malagari
14:30 - 14:45
TACE 2.0: Eluting beads: The latest !
Goetz M. Richter
14:45 - 15:00
Beyond TACE: Do degradable starch microspheres Philippe Pereira
put everything at stake ?
15:00 - 15:10
DISCUSSION
RADIOEMBOLIZATION - Chairmen: Elias Brountzos - Dario Poretti
15:10 - 15:30
Y90RE or TACE: That is the question
Robert Lewandowski
15:30 - 15:45
Do it superselectively or don’t bother
Roberto Cianni​
15:45 - 16:00
What’s new ? Lobar hypertrophy
Robert Lewandowski
16:00 - 16:10
DISCUSSION
16:10 - 16:30
COFFEE BREAK
METASTATIC LIVER - Chairmen: Giuseppe Curigliano - Robert Lewandowski
16:30 - 16:45
The DEBIRI affair: What you should know
Camillo Aliberti
16:45 - 16:55
Integration of SIR-Spheres Y resin
microspheres into the management
of colorectal metastases
Jens Ricke
16:55 - 17:10
Percutaneous hepatic chemoperfusion: Still alive ?
Mark Burgmans
17:10 - 17:25
NET: The essential role of interventional radiologists
Thierry de Baere​
17:25 - 17:35
The “Humanitas protocol” for treatment
of recurrence of mCRC after resection
Luca Viganò
17:35 - 17:45
DISCUSSION
17:45 - 18:30
GOLD MEDAL PRESENTATIONS HONORING SEMINAL
CONTRIBUTIONS TO INTERVENTIONAL ONCOLOGY
Chairmen: Luigi Solbiati - S. Nahum Goldberg - Franco Orsi
Italy: Tito Livraghi - United States: William Charboneau - China: Min-Hua Chen
90
14
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
Saturday, July 9th
CUTTING EDGE I O PRACTICE by ORGAN SYSTEM: Part 2
KIDNEY and ADRENAL - Chairmen: Victor Matei - Muneeb Ahmed
08:45 - 09:00
20 years of RFA for renal cell carcinoma:
Results and lessons learned
​​Franco Orsi
09:00 - 09:15
Renal mass ablation: What is the case for cryo ?
David Breen
09:15 - 09:30
Interventional Oncology for kidney familial disease
Brad Wood
09:30 - 09:45
When to treat the adrenal gland
Muneeb Ahmed
09:45 - 10:00
DISCUSSION
10:00 - 10:20
Keynote Lecture:
Mechanistic basis for improved TACE techniques
10:20 - 10:40
COFFEE BREAK
On streaming from Hong Kong
Jeff Geschwind
OTHER ORGANS - Chairman: Giovanni Carlo Anselmetti
10:40 - 11:00
What is the best way to ablate bone tumors ?
11:00 - 11:20
Expanding the role of I O in musculoskeletal procedures​ Alexis Kelekis
Roberto L. Cazzato
Chairman: Arturo Chiti
11:20 - 11:40
Breast cancer and ablation: What is the evidence ?
​​​Francesco Sardanelli
11:40 - 12:00
Ablation of thyroid cancers and cervical malignant
adenopathies
Jung Hwan Baek
12:00 - 12:15
DISCUSSION
12:15 - 12:35
Keynote Lecture: Chairman: Alexis Kelekis
Debunking current myths in clinical trial design:
Points of consideration for Interventional Radiology
12:35 - 13:15
Lunch Symposium RIVER GLOBAL HEALTHCARE
Riad Salem
US-Guided HIFU - Chairman: Holger Strunk
12.35 - 12.45
Introducing RGG Healthcare to the IR World
Piero Serra
12.45 - 13.00
Do you really know the power of USgHIFU in Oncology?
Franco Orsi
13.00 - 13.15
A real hope for pancreatic tumors
Zhiqiang Meng
15
13:50 - 15:00
BEST ABSTRACTS AWARDS
Chairmen: Luigi Solbiati - Nahum S. Goldberg - Franco Orsi
15:00 - 16:00
CLINICAL PEARLS
Muneeb Ahmed
Chairmen: Thomas Helmberger - Thierry deBaere Yasuaki Arai
Thomas Helmberger
16:00 - 16:50
CASES I WISH I DID DIFFERENTLY
Chairmen: Thomas Helmberger - Thierry de Baere
16:50 - 17:00
CONCLUSIONS
16
Roberto L. Cazzato
Thierry de Baere
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
Abstract
20
Thermal Ablation for Hepatocellular Carcinoma: A LargeScale Analysis of Long-term Outcome and Prognostic
Factors
China
Jianmin Ding, Xiang Jing, Yandong Wang,
Fengmei Wang,Yijun Wang
21
CT/MR-CEUS Image Fusion can Improve Thermal Ablation
Effects of HCC by Immediately Assessing Treatment Response and Guiding Additional Ablation during the Ablation
Procedures
China
Zhong-Zhen Su, Kai Li, Er-Jiao Xu,
Rong-Qin Zheng
26
Clinical utility of imaging fusion combining CEUS and MRI in
detection of HCCs undetectable by conventional ultrasound
before radiofrequency ablation
China
Yi Dong, Wen-Ping Wang, Feng Mao,
Zheng-Biao Ji, Hong Han, Bei-Jian Huang,
33
Local Therapy Combined with Sorafenib in the Treatment for
Advanced Initial Recurrent Hepatocellular Carcinoma after
Liver Resection
China
Manxia Lin, Baoxian Liu, Zhenwei Peng,
Guangyan Wei, Zihao Dai, Ming Kuang
34
Thermal Ablation for Benign Thyroid Nodules: Microwave
Ablation or Radiofrequency Ablation?
China
Hui-Xiong Xu, Wen-Wen Yue, Shu-Rong Wang,
Feng Lu, Li-Ping Sun
36
Treatment of Recurrent Hepatocellular Carcinoma: Laparoscopic Surgery versus Radiofrequency Ablation in A Large
Retrospective Comparative Multicenter Study Using Propensity Score Matching
China
Zhenwei Peng, Manxia Lin, Shuling Chen,
Zihao Dai, Guangyan Wei, Ming Kuang
40
Location and number of tumors: potential risk factors of liver
damage in thermal ablation
China
Yan Zhou, Jianming Ding, Xiang Jing
41
Efficacy of Single Dose Gonadotropin-Releasing Hormone
Agonist Administration Prior to Magnetic Resonance-Guided Focused Ultrasound Surgery for Symptomatic Uterine
Fibroids
South
Korea
Sang-Wook Yoon
47
Transvaginal Ultrasound-guided Tru-cut Biopsy of Pelvic
Masses: A Retrospective Study of 200 Cases
China
Xiao-Qing Pei, Shi-Yang Lin, Yong-Hong Xiong,
Miao Yun, Wei Zheng, An-Hua Li
48
Percutaneous radiofrequency ablation (RFTA) of single
lymphnode metastasis from hepatocellular carcinoma: initial
experience
Italy
49
Detection of residual tumors after ablation therapy: comparison of dynamic three-dimensional contrast-enhanced
ultrasound and contrast-enhanced computed tomography
China
Yandong Wang, Xiang Jing, Jianmin Ding
53
The Value of Contrast-Enhanced Ultrasound for Optimizing
Ultrasound-Guided Transthoracic Biopsy in Peripheral Pulmonary and Mediastinal Lesions
China
Song Wang, Wei Yang, Hui Zhang, Qian Xu,
Kun Yan, Minhua Chen
54
Radiofrequency Ablation: Minimizing thermal injury to adjacent structures using a novel thermo-sensitive matrigel
China
Fu Jing-Jing, Yang Wei, Wang Song, Wu Wei,
Yan Kun, Chen Min-Hua
55
Tumor Target Thermo-sensitive Liposomal Doxorubicin
Enhances the Efficacy of Drugs Accumulation and Animal
Survival
China
Wei Yang, Fei Yan, Song Wang, Jing-Jing Fu, Kun Yan,
Hai-Rong Zheng, Min-Hua Chen
56
CT-guided microwave ablation and percutaneous screw
fixation plus cementoplasty in the treatment of painful bone
metastases. Preliminary experience.
17
Italy
Mauro Mazzucco, Filippo Donelli,
Pietro Cattaneo, Alessandro Vario, Bortolo Perin
Pusceddu Claudio, Nicola Ballicu, Luca Melis
57
Endoscopic ultrasound-guided sampling using core biopsy
needle for diagnosis of left lobe hepatocellular carcinoma in
the cirrhosis background
China
Fen Chen, Tian’an Jiang
58
Real-time virtual navigation guided biopsy with US- PET/CT
fusion imaging for metastasis in chest and abdominal wall:
First experience
China
Tian’an Jiang, Fen Chen, Zhengdu Ye, Min Huang,
Liyun Zhong, Guo Tian, Chao Chen
60
CT-guided percutaneous laser ablation of small lung cancer:
a promising progress?
China
Guo Tian, Tian’an Jiang, Qiyu Zhao
63
Percutaneous laser ablation: a new contribution to unresectable metastatic retroperitoneal lesions?
China
Tian’an Jiang, Zhuang Deng, Fen Chen, Guo Tian,
Baohua Wang
64
Percutaneous microwave thermoablation (MWTA) of kidney
cancer up to 5 cm: long-term results
Italy
Mauro Mazzucco, Filippo Donelli,
Antonino Calabrò, Pietro Cattaneo, Alessandro Vario,
Lucia Anna Leone, Bortolo Perin
65
Personalized biomechanical modeling of prostate deformation based on elastography for MR-TRUS image registration
China
Ming Xu, Yi Wang, Chuan Peng, Xiao-Yan Xie
66
Shear wave elastography versus real-time elastography on
evaluation the ablation zone of rabbit liver:
A preliminary experimental study
China
Ming Xu, Xiao-Ju Li, Xiao-Er Zhang, Ming Liu,
Xiao-Yan Xie
67
Combined radiofrequency ablation and ethanol injection
versus hepatic resection for medium and large solitary
hepatocellular carcinomas
China
Zhenwei Peng, Shuling Chen, Manxia Lin,
Guangyan Wei, Zihao Dai, Ming Kuang
68
Clinical application in standardized treatment of
radiofrequency ablation in intractable liver malignant tumor
China
Lihua Cheng, Zhongzhi Jia, Bobo Wu
72
The value of Intraoperative real-time planning in retroperitoneal metastasis tumor treated by 125I brachytherapy
China
Zhang Lijuan, Zhao Xianzhi, Zhang Hongtao,
Wang Juan
73
The dosimetry study of 3D print template guided precision
125I seeds implantation
China
Zhang Hongtao, Di Xuemin, Yu Huimin,
Zhao Xianzhi, Zhang Lijuan, Zhao Jinxin,
Zhang Chen, Wang Juan
76
The preliminary efficacy of 125I seed implantation treated
retroperitoneal lymph node metastasis of recurrent cervical
cancer after radiotherapy
China
Di Xue-Min, Wang Ze-Yang, Ren Hong,
Yang Sheng-Jun, Zhao Xian-Zhi,Yu Hui-Min,
Zhang Hong-Tao, Wang Juan
79
The value of RFA in the treatment of large HCC adjacent to
the diaphragm
China
Wei Wu, Kun Yan, Jung-Chieh Lee, Wei Yang,
Zhong-Yi Zhang, Song Wang, Min-Hua Chen
80
Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment
China
Min-Hua Chen, Wei Yang, Kun Yan, Wei Wu,
Jung-Chieh Lee, Zhong-Yi Zhang, Song Wang
82
Radiofrequency Ablation of Liver Metastasis for the Treatment
of Pancreatic Cancer: Analysis of Safety and Efficacy
China
Yong-qiang Hua, Jun-Hua Lin, Xiao-Yan Zhu,
Ye-Hua Shen,Wang Peng, Zhi-Qiang Meng,
Zhen Chen, Hao Chen
83
Mono-modality fusion imaging with ultrasound: Is it a better
means to evaluate the therapeutic response of liver thermal
ablation?
China
Erjiao Xu, Yinglin Long, Kai Li, Zhongzhen Su,
Shumin Lv, Qingjin Zeng, Rongqin Zheng
87
Clinical application of ultrasound-guided radiofrequency
ablation of Hepatocellular carcinoma nearby liver surface
China
Jin-Yu Wu, Shu-Zhi Lin,Wei Wu, Kun Yan,
Quan Dai, Min-Hua Chen
88
Comparative study of the therapeutic outcome of percutaneous microwave coagulation therapy versus surgical resection
for the treatment of primary single small hepatocellular
carcinoma with cirrhosis
China
Hongchang Luo, Meng Gao, Wei Zhang,
Ruobing Liu, Sansan Li, Zhiyong Hong, Kaiyan Li
89
A clinical study of thermal monitoring techniques of ultrasound guided microwave ablation for hepatocellular carcinoma in high risk locations
China
Han Zhi-Yu, Liang Ping, Yu Xiao-Ling,
Cheng Zhi-Gang, Liu Fang-Yi, Yu Jie
18
93
A Three-dimensional Visualization Preoperative Treatment
Fangyi
Liu, Zhigang
Cheng, Zhiyu
Han, Xiaoling2016
Yu,
INTERVENTIONAL
ONCOLOGY
SANS
FRONTIERES
CONGRESS
Planning System for Microwave Ablation in Liver
Cancer:
China
Mingan Yu, Ping Liang
A Simulated Experimental Study
94
Long-term outcome of percutaneous ultrasound-guided
radiofrequency ablation for colorectal liver metastases
China
Kun Yan, Zhongyi Zhang, Minhua Chen, Wei Wu,
Wei Yang
96
Early assessment of the therapeutic response to radio
frequency ablation for hepatic local lesion with 3-dimensional
contrast-enhanced ultrasound (3D-CEUS) registration
system: a preliminary study
China
Zhang Xiaoer, Xu Ming, Xie Xiaoyan,
Cong Longfei, Sun Teng, Ye Jieyi, Lyu Mingde,
Huang Guangliang
101
The influence of needle depth on the accuracy of the dose
when 125I seeds implanted in malignant tumors guided by
3D print template
China
Yu Huimin, Zhang Hongtao, Zhao Xianzhi, Wang
Zeyang, Zhao Jinxin, Di Xuemin, Wang Juan
102
Safety and efficacy evaluation of high intensity focused ultrasound (HIFU) in patients with advanced pancreatic cancer
China
Zhiqiang Meng, Kun Wang, Yehua Shen,
Hao Chen, Zhen Chen
103
Survival Analysis for Unresectable Pancreatic Cancer Treated
with Transcatheter Arterial Chemotherapy
China
Yehua Shen, Qi Qi, Peng Wang, Zhen Chen,
Junhua Lin,Hao Chen, Zhiqiang Meng
105
The Assessment of Liver Ablation Using Two Dimensional
Shear Wave Elastography
China
Xiaoyan Xie, Liya Su, Manxia Lin, Ming Xu,
Ming Kuang, Mingde Lu
111
Comparison of cooled-probe microwave and radiofrequency
ablation treatment in incipient hepatocellular carcinoma: a
phase ? randomized controlled trial with 6-year follow-up
China
Yu Jie, Yu Xiao-Ling, Han Zhi-yu,
Cheng Zhi-Gang, Liu Fang-Yi, Zhai Hong-Yan,
Mu Meng-Juan, Liang Ping
113
Radiofrequency Ablation (RFA) using multiple-electrode
switching system for unresectable medium-large Hepatocellular Carcinoma (HCC) nodules. Preliminary experience
Italy
Giampiero Francica, Alfonso Ragozzino,
Federica Romano, Ettore Laccetti,
Cristiano Giardiello, Mariano Scaglione
114
Ablation treatment of hepatocellular carcinoma (hcc) nodules
under contrast-enhanced ultrasound (ceus) guidance. a
multicenter study
Italy
Giampiero Francica, Maria Franca Meloni,
Ilario de Sio, Maurizio Pompili, Eugenio Caturelli
117
Clinical study of correlation of blood perfusion characteristics
in liver cancer by contrast-enhanced ultrasonography and
individualized interventional therapy
China
118
New candidates’ selection and teaching paradigms in neurosurgery: preliminary experience at the Besta NeuroSim
Center
Italy
Alessandro Perin, Simone Nava, Sylvie Piacentini,
Luca Mattei, Tommaso Galbiati, Michele Tassi,
Dario Caldiroli, Francesco DiMeco
119
DEB-TACE with 40 micron drug eluting microspheres: early
results
Italy
R. Nani, A. Pecorelli, A. Ragnanese, R. Agazzi, S.
Sironi
120
US-Guided Core Biopsy of Lung Lesions
Italy
Roberto Nani, Anna Pecorelli, Gaetano Bonini,
Silvia Pesenti, Sandro Sironi
121
Microwave Ablation (MWA) of Liver Tumors with Real Time
US-CT/MRI Image Fusion/Virtual Needle-Track (US-CT/MRI
fusion/VNT) Guiding. A Single Center Experience.
Sweden
Anastasios Michos, Thomas Josephson,
Vitali Grozman, Evaldas Laurencikas
122
Irreversible Electroporation (IRE) of Liver Tumors with High
Frequency Jet Ventilation (HFJV) and Real Time US-CT Image
Fusion/Virtual Needle-Track (US-CTfusion/VNT) Guiding.
A Single Center Experience.
Sweden
Anastasios Michos,Thomas Josephson,
Vitali Grozman, Evaldas Laurencikas
123
Radiofrequency Ablation (RFA) of Kidney Tumors with High
Frequency Jet Ventilation (HFJV) and Real Time US-CT Image
Fusion/Virtual Needle-Track (US-CTfusion/VNT) Guiding.
A Single Center Experience.
Sweden
Anastasios Michos, Thomas Josephson,
Vitali Grozman, Evaldas Laurencikas
124
Percutaneous screw fixation and osteoplasty under
CT-flouroscopy guidance in pathological fractures.
Italy
19
SI Qin, Zhang Wenjie, Qian Xiaoli,
Huang Shengxi, Li Zengcai
Maria Cristina Fancello, Matteo Mammucari,
Sergio Capece, Mariella Sorarù, Teodoro Sava,
Ernesto Bissoli
125
Renal tumors with renal sinus extension: safety and effectivenes of image-guided thermal ablation
Italy
126
Percutaneous ablation of renal cell carcinoma using a high
power microwave system: focus upon safety and efficacy
Greece
Dimitrios Filippiadis, Argyro Mazioti,
Georgios Velonakis, Chrysostomos Kostantos,
Nikolaos Kelekis, Alexios Kelekis
127
Vertebral augmentation with the KIVA system in patients with
symptomatic malignant fractures in the thoracic spine
Greece
Dimitrios Filippiadis, Georgios Velonakis, Chrysostomos Kostantos, Argyro Mazioti,
Nikolaos Kelekis, Alexios Kelekis
128
Effect of tumor complexity on oncologic efficacy and complications in the percutaneous microwave ablation of T1a renal
cell carcinoma
USA
Shane A. Wells, E. Jason Abel,
Timothy J. Ziemlewicz, Sara L. Best,Meghan
G. Lubner, Fred T. Lee Jr, J. Louis Hinshaw,
USA
Shane A. Wells, E. Jason Abel,
Timothy J. Ziemlewicz, Sara L. Best,Meghan
G. Lubner, Fred T. Lee Jr, J. Louis Hinshaw
129
Local oncologic efficacy and safety of percutaneous thermal
ablation for metastatic renal cell carcinoma
Luca Nicosia, Giovanni Mauri, Franco Orsi,
Paolo della Vigna, Gianluca Maria Varano
130
Cryoablation or microwave ablation for localized T1a renal
cell carcinoma: Local oncologic efficacy and distant tumor
progression
USA
Shane A. Wells, E. Jason Abel,
Timothy J. Ziemlewicz, Sara L. Best,Meghan
G. Lubner, Fred T. Lee Jr, J. Louis Hinshaw
131
Can stereotactic body radiation therapy (SBRT) be an
effective and viable therapeutic option for inoperable HCC?
Results on 71 patients and 102 treated lesions.
Italy
Ciro Franzese,Tiziana Comito,Angelo Tozzi,
Cristina Iftode, Anna Maria Ascolese,
Fiorenza De Rose, Giuseppe Roberto D’Agostino,
Marta Scorsetti
132
Phase II trial on SBRT for unresectable Liver Metastases:
Long-term outcomes and prognostic factors of survival
Italy
Tiziana Comito, Lucia Di Brina, Ciro Franzese,
Angelo Tozzi, Piera Navarria, Cristina Iftode,
Davide Franceschini, Marta Scorsetti
134
Image-guided Radiofrequency Ablation of Lung tumours:
Experience at a tertiary centre in Singapore
Singapore
135
HIFU of Breast Fibroadenoma: a treat-and-resect case
Italy
Gabriele Levrini, Giuseppe Falco, Mauro Iori,
Guglielmo Ferrari, Moira Ragazzi,
Pierpaolo Pattacini
137
Ct-Guided rfa to treat osteoid osteoma: a 15-years experience at istituto ortopedico g.pini
Italy
Chiara De Angelis, Fabio Giardina, Stefano Bastoni,
Primo Daolio, Matteo Precerutti, Francesco Sardanelli, Mauro Gallazzi, Giancarlo Arborio
138
Periprocedural morbidity in patients undergoing ablation of
five or more lung metastases at a single treatment session
UK
Alice Gillams, Bill Lees
139
Ceus during and after tace in the management of patients
with HCC
Italy
Gianpaolo Vidili, Fabio Claudio, Gianni Pes,
Mario Maiore, Aldo Pischedda, Gianni Meloni,
Delitala Giuseppe
Apoorva Gogna, Leong Sum,Shaun Chan,
Nandakumar, Richard Lo, Karthikeyan,
Too Chow Wei, Farah Irani
E-posters
All accepted abstracts will be shown as e-Poster on a paperfree board instead of the traditional paper Poster.
Every monitor, located next to the Conference Room Entrance is a station, where every participant will be able to:
1.
Search for a poster using categories, topics, authors, title or abstract code
2.
Watch the abstract presentation as a printed one on the monitor
3.
Zoom in to see the details
4.
Vote for one abstract of each of the 4 categories
(Ablation - Transcatheter, Radiation Oncology and Bone Treatments - Imaging and Biopsy - Fusion)
(Instructions available on site)
Each abstract will be voted by the Scientific Committee and during the Congress by all the attendees
-
3 BEST ABSTRACTS will be awarded during Friday night Social Dinner
-
The best 7 abstracts will be orally presented during the dedicated Saturday Session
20
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
Congress Venue
Ata hotel Expo Fiera, the largest Hotel for
conferences near Milan’s new exhibition
centre (Fieramilano Rho/Pero) is designed
and built with “art technology”.
The Conference Centre, the common areas
and bedrooms are all equipped with free
Wi-Fi internet connection. The Hotel offers
450 rooms, including Superior, Executive,
Deluxe, Junior Suite and Corner Suites, as
well as 77 Residence-style apartments, all
soundproofed, bright and some with balcony, offering every comfort. The restaurant, overlooking the park and its beautiful
open-kitchen, the Lounge Bar, the Fitness Centre, a modern Business Centre and a large private
parking area, complete the wide range of services.
Address: Via Keplero, 12 - 20016 - Pero (Milan)
Distances:
Central Milan railway station: 12 km
Malpensa Airport: 40 km
Linate Airport: 40 km
Orio al Serio Airport: 55 km
Rho-Pero Exhibition Centre: 3 km
Malpensa fiere Exhibition Centre: 30 km
Parking:
ATA hotel Expo Fiera
has 400 parking lots with the
following costs:
€ 5 half day
€ 8 all day
€ 12 H24 for people who stay overnight
21
How to reach Atahotel Expo Fiera
From Central Station by public transport:
from Central Station take the underground (MM2 Green line - Abbiategrasso) and stop
at “Cadorna” station. From there change and take the underground line MM1, Red line direction Rho-Fiera and stop at “Molino Dorino” station.
A shuttle service “from and to” the hotel to Molino Dorino station - will be available from
7.00 am to 12.00 am, on request. This service is free. We recommend to wait for our
shuttle bus on the side of the station. Outside the shuttle bus service hours, we suggest to
get off at Pero underground station, which is about 600 meters from the hotel. Walk into
Via Olona, turn right into Via Pisacane and at the traffic lights turn left in via Keplero, the
hotel is 100 meters on the right.
From Linate Airport, by public transport:
from Linate Airport take the bus No. 73 (domestic arrivals area) and get off in “San Babila” station. From there take the underground line MM1, Red line - direction Rho-Fiera and
stop at “Molino Dorino” station.
A shuttle service “from and to” the hotel to Molino Dorino station - will be available from
7.00 am to 12.00 am, on request. This service is free. We recommend to wait for our
shuttle bus on the side of the station. Outside the shuttle bus service hours, we suggest to
get off at Pero underground station, which is about 600 meters from the hotel. Walk into
Via Olona, turn right into Via Pisacane and at the traffic lights turn left in via Keplero, the
hotel is 100 meters on the right.
From Malpensa Airport, by public transport:
directly at the terminal is expected the service “Malpensa Express” (one every 30 minutes) that goes to Cadorna Station in about 45 minutes. From there take the underground
line MM1, Red line - direction Rho-Fiera and stop at “Molino Dorino” station.
A shuttle service “from and to” the hotel to Molino Dorino station - will be available from
7.00 am to 12.00 am, on request. This service is free. We recommend to wait for our
shuttle bus on the side of the station. Outside the shuttle bus service hours, we suggest to
get off at Pero underground station, which is about 600 meters from the hotel. Walk into
Via Olona, turn right into Via Pisacane and at the traffic lights turn left in via Keplero, the
hotel is 100 meters on the right.
By car:
the Pero Sud exit on the motorway SP11 “Gallaratese” Milano-Novara (Tangenziale Ovest
exit) is only 300 meters away.
22
INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016
Main sponsors
Sponsors
Partner
23
Organizing Secretariat
ARSEDUCANDI Srl
Viale Gian Galeazzo, 3
20136 Milano, ITALY
Web: www.arseducandi.it
Congress Secretariat
Information/General
Telephone: + 39 02 58189.573
Fax: +39 02.58189.439
Email: [email protected]
Official
Travel Agency
PV Agency S.P.A
Viale Gian Galeazzo, 3
20136 Milano, ITALY
Web: www.pvagency.it
Hotel Accommodation
Telephone: + 39 02 58189.545
Fax: +39 02.58189.432
Email:
[email protected]
Hotel Accommodation
for Group
Telephone: + 39 02 58189.548
Fax: +39 02.58189.431
Email:
[email protected]
Registration
Telephone: + 39 02 58189.564
Fax: +39 02.58189.408
Email: [email protected]
Group Registration
Telephone: + 39 02 58189.571
Fax: +39 02.58189.471
Email:[email protected]
Speakers Contact
Telephone: + 39 02 58189.543
Fax: +39 02.58189.421
Email: [email protected]
Abstract Handling
Telephone: + 39 02 58189.552
Fax: +39 02.58189.428
Email: [email protected]
Exhibition & Sponsors
Telephone: + 39 02 58189.565
Fax: +39 02.58189.430
Email: [email protected]